• Overview
  
• About the CABERNET study
  
• Requirements for participation
  
• Enrollment & referral
  

Clinical Studies

Requirements for participation

Patients may qualify to participate in the CABERNET study if they are age 50 or older and have been diagnosed with new or recurrent wet AMD. Because use of Lucentis may present a risk for a fetus, women must show a negative pregnancy test, or have been postmenopausal for at least one year. Women who have had tubal ligation surgery or a hysterectomy may also be eligible.

Those who may not participate are men and women who have diabetes, who have recently received chemotherapy, or who have previously received any type of radiation treatment to the eye, head, or neck. Those patients who have received or are currently receiving treatment for wet AMD are also excluded.

Learn more by visiting the CABERNET website.